Literature DB >> 8408833

Antigen identification in drug-induced bullous pemphigoid.

E P Smith1, T B Taylor, L J Meyer, J J Zone.   

Abstract

Immunobullous diseases usually develop spontaneously, but drug-induced bullous disease develops in a small subgroup of patients. We examined a patient in whom bullous pemphigoid developed after she received enalapril for treatment of hypertension. IgG antibody directed against a 230 kd antigen was identified. The eluted IgG autoantibody was shown to bind to the basement membrane zone on split skin. This study demonstrates that drug-induced bullous pemphigoid autoantibody in this patient was directed against the same antigen as the spontaneous bullous pemphigoid antigen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408833     DOI: 10.1016/0190-9622(93)70262-r

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction.

Authors:  Rami A Ballout; Umayya Musharrafieh; Joe Khattar
Journal:  Br J Clin Pharmacol       Date:  2018-08-29       Impact factor: 4.335

3.  A Systematic Review of Drug-Induced Pemphigoid.

Authors:  Matthew J Verheyden; Asli Bilgic; Dédée F Murrell
Journal:  Acta Derm Venereol       Date:  2020-08-17       Impact factor: 3.875

4.  Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis.

Authors:  Connie Qiu; Alina Shevchenko; Sylvia Hsu
Journal:  JAAD Case Rep       Date:  2020-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.